Truqap can be a kinase inhibitor that works by blocking pathways that help the most cancers cells endure and increase, so lessens cancer progress. Truqap is from a class of medicines named an AKT inhibitor. Truqap gained FDA approval on November seventeen, 2023, after good success through the CAPItello-291 Section https://6-hydroxypaclitaxel45790.blog5star.com/35281276/rumored-buzz-on-rituximab